ADAM17 and neoplasm: In another study, miR-3163 has been identified as a tumor suppressor in hepatocellular carcinoma (HCC) through inhibition of ADAM metalloprotease domain-17 (ADAM17), leading to decreased activation of the Notch signaling pathway (37).